INT345506

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.00
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.08
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Golgi apparatus (EGFR, FNDC3A) extracellular space (EGFR) plasma membrane (EGFR)
nucleus (EGFR) endosome (EGFR) cell morphogenesis (EGFR)
EGFR (Homo sapiens)
FNDC3A (Homo sapiens)
Pain Link Frequency Relevance Heat
adenocard 1 5.72 Low Low
palliative 5 5.00 Very Low Very Low Very Low
agonist 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
General Immunology 1 80.48 Quite High
Squamous Cell Carcinoma 2 38.08 Quite Low
Non-small-cell Lung Cancer 47 30.32 Quite Low
Cancer 24 5.00 Very Low Very Low Very Low
Toxicity 11 5.00 Very Low Very Low Very Low
Colon Cancer 11 5.00 Very Low Very Low Very Low
Lung Cancer 6 5.00 Very Low Very Low Very Low
Disease 6 5.00 Very Low Very Low Very Low
Metastasis 4 5.00 Very Low Very Low Very Low
Solid Tumor 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Recreation of 3-specific murine amino acids (Serine 75, Threonine (Thr) 76, and Thr 93) in the new antibody’s variable fraction preserved their anti-EGFR activity.34 Although a crystallized protein model has yet to be completed, a likely hypothesis for nimotuzumab binding to domain III of EGFR’s extracellular region was developed by Talavera et al35 based on observed competition with cetuximab and computer simulations.
EGFR Binding (binding) of domain III
1) Confidence 0.00 Published 2010 Journal Biologics : Targets & Therapy Section Body Doc Link PMC2990321 Disease Relevance 0.08 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox